Vasopressin therapy in Parkinson's disease.
A double-blind crossover pilot study was carried out in six patients with Parkinson's disease in order to test the possible therapeutic effect of L-vasopressin after treatment for 1 month with 30 I.U. intranasally daily. The investigation was completed in five cases. No effects was noticed after LVP treatment.
D000281:Administration, Intranasal; D000368:Aged; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D010865:Pilot Projects; D014667:Vasopressins / Q000627:therapeutic use*
D014667:Vasopressins